• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用乌干达病毒研究所的血浆标本参考面板评估 25 种 SARS-CoV-2 血清学快速诊断检测试剂的性能。

Evaluation of the performance of 25 SARS-CoV-2 serological rapid diagnostic tests using a reference panel of plasma specimens at the Uganda Virus Research Institute.

机构信息

Uganda Virus Research Institute, PO Box 49, Plot 51-59, Nakiwogo Road, Entebbe, Uganda.

Uganda Virus Research Institute, PO Box 49, Plot 51-59, Nakiwogo Road, Entebbe, Uganda; Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine, Uganda Research Unit, PO Box 49, Plot 1-59, Nakiwogo Road, Entebbe, Uganda.

出版信息

Int J Infect Dis. 2021 Nov;112:281-287. doi: 10.1016/j.ijid.2021.09.020. Epub 2021 Sep 15.

DOI:10.1016/j.ijid.2021.09.020
PMID:34536612
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8442260/
Abstract

INTRODUCTION

Serological testing is needed to better understand the epidemiology of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. Rapid diagnostic tests (RDTs) have been developed to detect specific antibodies, IgM and IgG, to the virus. The performance of 25 of these RDTs was evaluated.

METHODS

A serological reference panel of 50 positive and 100 negative plasma specimens was developed from SARS-CoV-2 PCR and antibody positive patients and pre-pandemic SARS-CoV-2-negative specimens collected in 2016. Test performance of the 25 RDTs was evaluated against this panel.

RESULTS

A total of 10 RDTs had a sensitivity ≥98%, while 13 RDTs had a specificity ≥98% to anti-SARS-CoV-2 IgG antibodies. Four RDTs (Boson, MultiG, Standard Q, and VivaDiag) had both sensitivity and specificity ≥98% to anti-SARS-CoV-2 IgG antibodies. Only three RDTs had a sensitivity ≥98%, while 10 RDTs had a specificity ≥98% to anti-SARS-CoV-2 IgM antibodies. Three RDTs (Autobio, MultiG, and Standard Q) had sensitivity and specificity ≥98% to combined IgG/IgM. The RDTs that performed well also had perfect or almost perfect inter-reader agreement.

CONCLUSIONS

This evaluation identified three RDTs with a sensitivity and specificity to IgM/IgG antibodies of ≥98% with the potential for widespread antibody testing in Uganda.

摘要

简介

血清学检测对于更好地了解严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)病毒的流行病学情况非常重要。已经开发出快速诊断检测(RDT)来检测针对该病毒的特异性抗体,即 IgM 和 IgG。本文评估了其中 25 种 RDT 的性能。

方法

从 SARS-CoV-2 PCR 和抗体阳性患者以及 2016 年采集的大流行前 SARS-CoV-2 阴性标本中开发了一个包含 50 份阳性和 100 份阴性血浆标本的血清学参考面板。针对该参考面板评估了这 25 种 RDT 的检测性能。

结果

共有 10 种 RDT 的抗 SARS-CoV-2 IgG 抗体检测敏感性≥98%,13 种 RDT 的特异性≥98%。4 种 RDT(Boson、MultiG、Standard Q 和 VivaDiag)对 IgG 抗体的敏感性和特异性均≥98%。只有 3 种 RDT 的敏感性≥98%,而 10 种 RDT 的特异性≥98%抗 SARS-CoV-2 IgM 抗体。3 种 RDT(Autobio、MultiG 和 Standard Q)对 IgG/IgM 同时具有高敏感性和特异性。性能良好的 RDT 也具有完美或近乎完美的读者间一致性。

结论

本评价鉴定出了 3 种敏感性和特异性≥98%的 IgM/IgG 抗体 RDT,它们可能在乌干达广泛用于抗体检测。

相似文献

1
Evaluation of the performance of 25 SARS-CoV-2 serological rapid diagnostic tests using a reference panel of plasma specimens at the Uganda Virus Research Institute.利用乌干达病毒研究所的血浆标本参考面板评估 25 种 SARS-CoV-2 血清学快速诊断检测试剂的性能。
Int J Infect Dis. 2021 Nov;112:281-287. doi: 10.1016/j.ijid.2021.09.020. Epub 2021 Sep 15.
2
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
3
Evaluation of ten (10) SARS-CoV-2 rapid serological tests in comparison with WANTAI SARS-CoV-2 ab ELISA in Burkina Faso, West Africa.评估十种(10)种 SARS-CoV-2 快速血清学检测试剂在西非布基纳法索与万泰 SARS-CoV-2 ab ELISA 的比较。
Virol J. 2023 Mar 30;20(1):57. doi: 10.1186/s12985-023-02011-4.
4
Diagnosis value of SARS-CoV-2 antigen/antibody combined testing using rapid diagnostic tests at hospital admission.入院时使用快速诊断检测进行 SARS-CoV-2 抗原/抗体联合检测的诊断价值。
J Med Virol. 2021 May;93(5):3069-3076. doi: 10.1002/jmv.26855. Epub 2021 Feb 15.
5
Analytical performances of five SARS-CoV-2 whole-blood finger-stick IgG-IgM combined antibody rapid tests.五种 SARS-CoV-2 全血手指点刺 IgG-IgM 联合抗体快速检测试剂的分析性能。
J Virol Methods. 2021 Apr;290:114067. doi: 10.1016/j.jviromet.2021.114067. Epub 2021 Jan 18.
6
Unexpected high frequency of unspecific reactivities by testing pre-epidemic blood specimens from Europe and Africa with SARS-CoV-2 IgG-IgM antibody rapid tests points to IgM as the Achilles heel.用 SARS-CoV-2 IgG-IgM 抗体快速检测试剂盒检测来自欧洲和非洲的大流行前血标本时,出现了出乎意料的高频率非特异性反应,这表明 IgM 是“阿喀琉斯之踵”。
J Med Virol. 2021 Apr;93(4):2196-2203. doi: 10.1002/jmv.26628. Epub 2020 Nov 22.
7
Clinical diagnostic performance evaluation of five immunoassays for antibodies to SARS-CoV-2 diagnosis in a real-life routine care setting.五种用于 SARS-CoV-2 抗体诊断的免疫分析方法在真实临床常规检测环境中的临床诊断性能评估。
Pan Afr Med J. 2021 May 3;39:3. doi: 10.11604/pamj.2021.39.3.26471. eCollection 2021.
8
Antibody tests for identification of current and past infection with SARS-CoV-2.用于识别当前和既往感染新型冠状病毒2的抗体检测。
Cochrane Database Syst Rev. 2020 Jun 25;6(6):CD013652. doi: 10.1002/14651858.CD013652.
9
Comparative evaluation of RT-PCR and antigen-based rapid diagnostic tests (Ag-RDTs) for SARS-CoV-2 detection: performance, variant specificity, and clinical implications.实时荧光 RT-PCR 与抗原检测试剂用于 SARS-CoV-2 检测的比较评估:性能、变异株特异性和临床意义。
Microbiol Spectr. 2024 Jun 4;12(6):e0007324. doi: 10.1128/spectrum.00073-24. Epub 2024 Apr 29.
10
Diagnostic Efficacy of 11 SARS-CoV-2 Serological Assays for COVID-19: A Meta-Analysis and Adjusted Indirect Comparison of Diagnostic Test Accuracy.11种新型冠状病毒2型血清学检测方法对冠状病毒病的诊断效能:诊断试验准确性的Meta分析和校正间接比较
Immun Inflamm Dis. 2024 Dec;12(12):e70114. doi: 10.1002/iid3.70114.

引用本文的文献

1
Safety and Immunogenicity of a Modified Self-Amplifying Ribonucleic Acid (saRNA) Vaccine Encoding SARS-CoV-2 Spike Glycoprotein in SARS-CoV-2 Seronegative and Seropositive Ugandan Individuals.编码严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突糖蛋白的改良自扩增核糖核酸(saRNA)疫苗在乌干达SARS-CoV-2血清阴性和血清阳性个体中的安全性和免疫原性
Vaccines (Basel). 2025 May 23;13(6):553. doi: 10.3390/vaccines13060553.
2
Seroprevalence and risk factors for SARS-CoV-2 infection in middle-sized cities of Burkina Faso: A descriptive cross-sectional study.布基纳法索中等城市 SARS-CoV-2 感染的血清流行率和危险因素:一项描述性横断面研究。
PLoS One. 2024 Aug 7;19(8):e0305850. doi: 10.1371/journal.pone.0305850. eCollection 2024.
3
Re-testing as a method of implementing external quality assessment program for COVID-19 real time PCR testing in Uganda.在乌干达,重新检测作为实施 COVID-19 实时 PCR 检测外部质量评估计划的一种方法。
PLoS One. 2024 Jan 24;19(1):e0287272. doi: 10.1371/journal.pone.0287272. eCollection 2024.
4
A phase I COVID-19 vaccine trial among SARS-CoV-2 seronegative and seropositive individuals in Uganda utilizing a self-amplifying RNA vaccine platform: Screening and enrollment experiences.在乌干达利用自我扩增 RNA 疫苗平台对 SARS-CoV-2 血清阴性和血清阳性个体进行的 I 期 COVID-19 疫苗试验:筛选和入组经验。
Hum Vaccin Immunother. 2023 Aug 1;19(2):2240690. doi: 10.1080/21645515.2023.2240690.
5
Optimisation and Validation of a conventional ELISA and cut-offs for detecting and quantifying anti-SARS-CoV-2 Spike, RBD, and Nucleoprotein IgG, IgM, and IgA antibodies in Uganda.优化和验证常规 ELISA 方法及其 cutoff 值,以用于在乌干达检测和定量抗 SARS-CoV-2 刺突蛋白、受体结合域以及核衣壳蛋白 IgG、IgM 和 IgA 抗体。
Front Immunol. 2023 Mar 14;14:1113194. doi: 10.3389/fimmu.2023.1113194. eCollection 2023.
6
SARS-CoV-2 Testing Strategies in the Diagnosis and Management of COVID-19 Patients in Low-Income Countries: A Scoping Review.低收入国家 COVID-19 患者诊断和管理中的 SARS-CoV-2 检测策略:范围综述。
Mol Diagn Ther. 2023 May;27(3):303-320. doi: 10.1007/s40291-022-00637-8. Epub 2023 Jan 27.
7
False Positivity of Anti-SARS-CoV-2 Antibodies in Patients with Acute Tropical Diseases in Thailand.泰国急性热带病患者中抗SARS-CoV-2抗体的假阳性
Trop Med Infect Dis. 2022 Jul 12;7(7):132. doi: 10.3390/tropicalmed7070132.

本文引用的文献

1
Performance of 30 commercial SARS-CoV-2 serology assays in testing symptomatic COVID-19 patients.30 种商业 SARS-CoV-2 血清学检测试剂盒在检测有症状 COVID-19 患者中的表现。
Eur J Clin Microbiol Infect Dis. 2021 Oct;40(10):2235-2241. doi: 10.1007/s10096-021-04232-3. Epub 2021 Mar 29.
2
Five reasons why COVID herd immunity is probably impossible.新冠病毒群体免疫可能无法实现的五个原因。
Nature. 2021 Mar;591(7851):520-522. doi: 10.1038/d41586-021-00728-2.
3
Implementing COVID-19 (SARS-CoV-2) Rapid Diagnostic Tests in Sub-Saharan Africa: A Review.在撒哈拉以南非洲实施新型冠状病毒肺炎(严重急性呼吸综合征冠状病毒2)快速诊断检测:一项综述
Front Med (Lausanne). 2020 Oct 30;7:557797. doi: 10.3389/fmed.2020.557797. eCollection 2020.
4
A comparative evaluation between the Abbott Panbio™ COVID-19 IgG/IgM rapid test device and Abbott Architect™ SARS CoV-2 IgG assay. Abbott Panbio™ COVID-19 IgG/IgM 快速检测试剂盒与 Abbott Architect™ SARS-CoV-2 IgG 检测试剂盒的比较评估。
J Clin Virol. 2020 Nov;132:104645. doi: 10.1016/j.jcv.2020.104645. Epub 2020 Sep 16.
5
Evaluation of Orthogonal Testing Algorithm for Detection of SARS-CoV-2 IgG Antibodies.正交测试算法检测 SARS-CoV-2 IgG 抗体的评价。
Clin Chem. 2020 Dec 1;66(12):1531-1537. doi: 10.1093/clinchem/hvaa210.
6
Antibody tests for identification of current and past infection with SARS-CoV-2.用于识别当前和既往感染新型冠状病毒2的抗体检测。
Cochrane Database Syst Rev. 2020 Jun 25;6(6):CD013652. doi: 10.1002/14651858.CD013652.
7
Serology characteristics of SARS-CoV-2 infection after exposure and post-symptom onset.感染 SARS-CoV-2 后的血清学特征:暴露后及症状出现后。
Eur Respir J. 2020 Aug 27;56(2). doi: 10.1183/13993003.00763-2020. Print 2020 Aug.
8
Antibody responses to SARS-CoV-2 in patients with COVID-19.新型冠状病毒肺炎(COVID-19)患者的 SARS-CoV-2 抗体反应。
Nat Med. 2020 Jun;26(6):845-848. doi: 10.1038/s41591-020-0897-1. Epub 2020 Apr 29.
9
Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019.新型冠状病毒病 2019 患者的 SARS-CoV-2 抗体反应。
Clin Infect Dis. 2020 Nov 19;71(16):2027-2034. doi: 10.1093/cid/ciaa344.
10
Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study.SARS-CoV-2 感染后口咽后唾液样本和血清抗体反应中的病毒载量时间特征:一项观察性队列研究。
Lancet Infect Dis. 2020 May;20(5):565-574. doi: 10.1016/S1473-3099(20)30196-1. Epub 2020 Mar 23.